Evidence map›Paper›PMID 40188103›Full record

ArticleNature communications2025

Sperm derived H2AK119ub1 is required for embryonic development in Xenopus laevis.

Valentin Francois-Campion, Florian Berger, Mami Oikawa, Maissa Goumeidane, Nolwenn Mouniée, Vanessa Chenouard, Kseniya Petrova, Jose G Abreu, Cynthia Fourgeux, Jeremie Poschmann and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Valentin Francois-Campion *Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0009-0009-3241-2281
Florian Berger *Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0009-0002-8176-8830
Mami OikawaLaboratory of Regenerative Medicine, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo, Japan.
Maissa GoumeidaneNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
Nolwenn MouniéeNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0009-0005-3752-833X
Vanessa ChenouardNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0000-0003-2385-8299
Kseniya PetrovaSystems Biology, Harvard Medical School, Boston, MA, USA.
Jose G AbreuSystems Biology, Harvard Medical School, Boston, MA, USA.
Cynthia FourgeuxNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0000-0002-3330-7530
Jeremie PoschmannNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.ORCID http://orcid.org/0000-0002-9613-5297
Leonid PeshkinSystems Biology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6420-848X
Romain GibeauxUniv Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, Rennes, France.ORCID http://orcid.org/0000-0001-5081-1985
Jérôme JullienNantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France. jerome.jullien@inserm.fr.ORCID http://orcid.org/0000-0002-7868-0021

Funding

XenCAT: Xenopus Single Cell AtlasR24OD031956 · OD · HARVARD MEDICAL SCHOOL · PI PESHKIN, LEON · 2022 to 2025
$3.5M
NIH HHS R24 OD031956
6 · The paper itself

Abstract

Ubiquitylation of H2A (H2AK119ub1) by the polycomb repressive complexe-1 plays a key role in the initiation of facultative heterochromatin formation in somatic cells. Here we evaluate the contribution of sperm derived H2AK119ub1 to embryo development. In Xenopus laevis we found that H2AK119ub1 is present during spermiogenesis and into early embryonic development, highlighting its credential for a role in the transmission of epigenetic information from the sperm to the embryo. In vitro treatment of sperm with USP21, a H2AK119ub1 deubiquitylase, just prior to injection to egg, results in developmental defects associated with gene upregulation. Sperm H2AK119ub1 editing disrupts egg factor mediated paternal chromatin remodelling processes. It leads to post-replication accumulation of H2AK119ub1 on repeat element of the genome instead of CpG islands. This shift in post-replication H2AK119ub1 distribution triggered by sperm epigenome editing entails a loss of H2AK119ub1 from genes misregulated in embryos derived from USP21 treated sperm. We conclude that sperm derived H2AK119ub1 instructs egg factor mediated epigenetic remodelling of paternal chromatin and is required for embryonic development.

Indexed as

Embryonic DevelopmentHistonesSpermatozoaXenopus laevisXenopus ProteinsAnimalsChromatinChromatin Assembly and DisassemblyEmbryo, NonmammalianEpigenesis, GeneticFemaleGene Expression Regulation, DevelopmentalMaleSpermatogenesisUbiquitinationUbiquitin ThiolesteraseChromatinHistonesUbiquitin ThiolesteraseXenopus Proteins

Identifiers

PMID40188103
PMCPMC11972363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.